Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: What do primary care physicians think?
Journal
Vaccine
Journal Volume
30
Journal Issue
48
Pages
6731-6733
Date Issued
2012
Author(s)
O'Leary S.T.
Suh C.A.
Marin M.
Daley M.F.
Broder K.
Crane L.A.
Babbel C.I.
Barrow J.
Stokley S.
Beaty B.
Dickinson L.M.
Kempe A.
Abstract
Purpose: Measles-mumps-rubella-varicella (MMRV) vaccine is associated with increased febrile seizure risk compared with measles-mumps-rubella and varicella vaccine given separately (MMR. +. V) in children 12-15-month old. We assessed knowledge regarding MMRV and febrile seizures, intended practices, and factors influencing the decision to recommend MMRV. Methods: National survey administered 10/2008-1/2009 of US pediatricians (Peds) and family physicians (FP). Results: Response rate was 73% (620/849). Twenty-nine percent of Peds and 74% of FP (p<. 0.001) were unaware of increased febrile seizure risk after MMRV. After reading an informational statement, 20% of Peds and 7% of FP (p<. 0.001) would recommend MMRV to a healthy 12-15-month-old child. The factor most frequently reported as " very important" in the decision to recommend MMRV or MMR. +. V was ACIP/AAFP/AAP recommendations (pediatricians, 77%, family physicians, 73%, p= 0.08). Conclusions: After receiving data regarding febrile seizure risk after MMRV, few physicians report they would recommend MMRV to a healthy 12-15-month-old child. © 2012 Elsevier Ltd.
SDGs
Type
journal article